Company

Hana Pharm Co. Ltd

Headquarters: Seoul, South Korea

CEO: Mr. Yunha Lee

KRX: 293480 -0.69%

Market Cap

₩181.13 Billion

KRW as of Jan. 1, 2025

US$123.2 Million

Market Cap History

Hana Pharm Co. Ltd Categories

South Korea Healthcare Drug Manufacturers—Specialty & Generic
South Korea Healthcare South Korea Drug Manufacturers—Specialty & Generic

Hana Pharm Co. Ltd market capitalization over time

Evolution of Hana Pharm Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Hana Pharm Co. Ltd

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $75.33 B
MERCK Kommanditgesellschaft auf Aktien $65.17 B
Haleon plc $42.16 B
Takeda Pharmaceutical Company Limited $41.47 B
Teva Pharmaceutical Industries Limited $18.95 B
Sector:
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Detailed Description

Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1958 and is headquartered in Seoul, South Korea.

Stocks & Indices

Hana Pharm Co. Ltd has the following listings and related stock indices.


Stock: KRX: 293480 wb_incandescent

Details

Headquarters:

Narae Building

15th and 16th Floors 218 Teheran-ro Gangnam-Gu

Seoul, None

South Korea

Phone: 82 2 577 7667

Fax: 82 2 566 6003